Weil, Ana A. http://orcid.org/0000-0002-6170-4306
Luiten, Kyle G. http://orcid.org/0000-0003-4473-5714
Casto, Amanda M. http://orcid.org/0000-0001-8332-8578
Bennett, Julia C. http://orcid.org/0000-0003-2559-2922
O’Hanlon, Jessica
Han, Peter D.
Gamboa, Luis S.
McDermot, Evan
Truong, Melissa
Gottlieb, Geoffrey S.
Acker, Zack
Wolf, Caitlin R.
Magedson, Ariana
Chow, Eric J. http://orcid.org/0000-0003-3349-9330
Lo, Natalie K.
Pothan, Lincoln C.
McDonald, Devon
Wright, Tessa C.
McCaffrey, Kathryn M.
Figgins, Marlin D.
Englund, Janet A.
Boeckh, Michael
Lockwood, Christina M.
Nickerson, Deborah A.
Shendure, Jay http://orcid.org/0000-0002-1516-1865
Bedford, Trevor
Hughes, James P.
Starita, Lea M.
Chu, Helen Y.
Article History
Received: 29 April 2022
Accepted: 15 August 2022
First Online: 6 September 2022
Competing interests
: H.Y.C. reports consulting with Ellume, Pfizer, The Bill and Melinda Gates Foundation, Glaxo Smith Kline, and Merck. H.Y.C. received research funding from Gates Ventures, Sanofi Pasteur, and support and reagents from Ellume and Cepheid outside of the submitted work. G.S.G. received research grants and research support from the US National Institutes of Health, the University of Washington, the Bill & Melinda Gates Foundation, Gilead Sciences, Alere Technologies, Merck & Co., Janssen Pharmaceutica, Cerus Corporation, ViiV Healthcare, Bristol-Myers Squibb, Roche Molecular Systems, Abbott Molecular Diagnostics, and THERA Technologies/TaiMed Biologics, Inc, all outside of the submitted work. J.A.E. reports research support from Gates Ventures, AstraZeneca, GlaxoSmithKline, Merck, and Pfizer, and consulting with Sanofi Pasteur, AstraZeneca, Teva Pharmaceuticals, and Meissa Vaccines, outside of the submitted work. M.B. reports research support from Vir Biotechnology, GSK, Regeneron, Gilead Sciences, Janssen Pharmaceutica, Ridgeback, Merck, Gates Ventures, and consulting with Vir Biotechnology, Moderna, Helocyte, and Merck outside of the submitted work. The remaining authors declare no competing interests.